130
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Chonggu Granules Improve Cartilage Matrix Metabolism in Knee Osteoarthritis via the miR-148a-3p/Wnt/β-Catenin Pathway

, , , , &
Pages 4751-4762 | Received 02 Aug 2023, Accepted 27 Sep 2023, Published online: 20 Oct 2023

References

  • Kan HS, Chan PK, Chiu KY, et al. Non-surgical treatment of knee osteoarthritis. Hong Kong Med J. 2019;25(2):127–133. doi:10.12809/hkmj187600
  • Michael JW, Schluter-Brust KU, Eysel P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int. 2010;107(9):152–162. doi:10.3238/arztebl.2010.0152
  • Lespasio MJ, Piuzzi NS, Husni ME, Muschler GF, Guarino A, Mont MA. Knee Osteoarthritis: a Primer. Perm J. 2017;21:16–183. doi:10.7812/TPP/16-183
  • Li MC, Leng XM. Small symptoms, big burden: an overview of the epidemiology of osteoarthritis. Chin J Clinical Immunol Allergy. 2012;16(3):331.
  • Hussain SM, Neilly DW, Baliga S, Patil S, Meek R. Knee osteoarthritis: a review of management options. Scott Med J. 2016;61(1):7–16. doi:10.1177/0036933015619588
  • Cheng HC, Tang ZF. Clinical observation on the treatment of 30 cases of knee osteoarthritis with liver and kidney deficiency with Chonggu granules. Rheumatism and Arthritis. 2021;10(12):7–10+15.
  • Xueshan C. Effect of Chonggu granule on knee osteoarthritis with liver-kidney deficiency and its influence on cartilage matrix metabolism. Anhui Univ Traditional Chine Med. 2022.
  • Shu PL, Li YF, Fu WL, Huang CB. Clinical efficacy of Chonggu granule in the treatment of knee osteoarthritis with liver and kidney deficiency and its effect on bone metabolism indexes. Clin Efficacy Chonggu. 2023;42(01):31–35.
  • Mendell JT. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle. 2005;4(9):1179–1184. doi:10.4161/cc.4.9.2032
  • Soyocak A, Kurt H, Ozgen M, Turgut Cosan D, Colak E, Gunes HV. miRNA-146a, miRNA-155 and JNK expression levels in peripheral blood mononuclear cells according to grade of knee osteoarthritis. Gene. 2017;627:207–211. doi:10.1016/j.gene.2017.06.027
  • Li SH, Wu QF. MicroRNAs target on cartilage extracellular matrix degradation of knee osteoarthritis. Eur Rev Med Pharmacol Sci. 2021;25(3):1185–1197. doi:10.26355/eurrev_202102_24821
  • Jones SW, Watkins G, Le Good N, et al. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthritis Cartilage. 2009;17(4):464–472. doi:10.1016/j.joca.2008.09.012
  • Shang X, Boker KO, Taheri S, Hawellek T, Lehmann W, Schilling AF. The Interaction between microRNAs and the Wnt/beta-Catenin Signaling Pathway in Osteoarthritis. Int J Mol Sci. 2021;22(18). doi:10.3390/ijms22189887
  • Yu H, Liu Y, Yang X, et al. Strontium ranelate promotes chondrogenesis through inhibition of the Wnt/beta-catenin pathway. Stem Cell Res Ther. 2021;12(1):296. doi:10.1186/s13287-021-02372-z
  • Tamamura Y, Otani T, Kanatani N, et al. Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J Biol Chem. 2005;280(19):19185–19195. doi:10.1074/jbc.M414275200
  • Dong Z, Jiang H, Jian X, Zhang W. Change of miRNA expression profiles in patients with knee osteoarthritis before and after celecoxib treatment. J Clin Lab Anal. 2019;33(1):e22648. doi:10.1002/jcla.22648
  • Zhang L, Cheng H, Yue Y, Li S, Zhang D, He R. H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/beta-catenin in ox-LDL -stimulated vascular smooth muscle cells. J Biomed Sci. 2018;25(1):11. doi:10.1186/s12929-018-0418-4
  • Yao N, Chen GC, Lu YY, et al. Bushen Qiangjin capsule inhibits the Wnt/α-catenin pathway to ameliorate papain-induced knee osteoarthritis in rat. J Traditional Chine Med. 2021;41(6):935–942. doi:10.19852/j.cnki.jtcm.2021.06.010
  • Liu J, Liu S, Pan W, Li Y. Wogonoside attenuates the articular cartilage injury and the infiltration of Th1/Th2-type cytokines in papain-induced osteoarthritis in rat model via inhibiting the NF-κB and ERK1/2 activation. Immunopharmacol Immunotoxicol. 2021;43(3):343–352. doi:10.1080/08923973.2021.1913503
  • Xie ZH. Research progress of traditional Chinese medicine intervention for osteoarthritis based on Wnt/β-catenin signaling pathway. Chine J Osteoporosis. 2018;24(05):664–670.
  • Murat N, Karadam B, Ozkal S, Karatosun V, Gidener S. [Quantification of papain-induced rat osteoarthritis in relation to time with the Mankin score]. Acta Orthop Traumatol Turc. 2007;41(3):233–237.
  • Hodgkinson T, Kelly DC, Curtin CM, O’Brien FJ. Mechanosignalling in cartilage: an emerging target for the treatment of osteoarthritis. Nat Rev Rheumatol. 2022;18(2):67–84. doi:10.1038/s41584-021-00724-w
  • Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33–42. doi:10.1038/nrrheum.2010.196
  • Cong S, Meng Y, Wang L, Sun J. T-614 attenuates knee osteoarthritis via regulating Wnt/beta-catenin signaling pathway. J Orthop Surg Res. 2021;16(1):403. doi:10.1186/s13018-021-02530-2
  • Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149(6):1192–1205. doi:10.1016/j.cell.2012.05.012
  • van den Bosch MH, Blom AB, van de Loo FA, et al. Brief Report: induction of Matrix Metalloproteinase Expression by Synovial Wnt Signaling and Association With Disease Progression in Early Symptomatic Osteoarthritis. Arthritis Rheumatol. 2017;69(10):1978–1983. doi:10.1002/art.40206
  • Bai M, Ge L, Chen H, Jin Q. Calcitonin protects rat chondrocytes from IL-1beta injury via the Wnt/beta-catenin pathway. Exp Ther Med. 2019;18(3):2079–2085. doi:10.3892/etm.2019.7806
  • Vonk LA, Kragten AH, Dhert WJ, Saris DB, Creemers LB. Overexpression of hsa-miR-148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes. Osteoarthritis Cartilage. 2014;22(1):145–153. doi:10.1016/j.joca.2013.11.006
  • Peng L, Liu Z, Xiao J, et al. MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/beta-catenin signaling pathway. Oncol Rep. 2017;38(1):301–308. doi:10.3892/or.2017.5705
  • Jiang Q, He M, Ma MT, et al. MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1. Oncol Rep. 2016;35(3):1425–1432. doi:10.3892/or.2015.4502